Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ImmuLogic files U.S. IND application for MS therapeutic

Jan. 7, 1997

First launch for Sumitomo antidepressant

Jan. 7, 1997

Novel analgesic/antiinflammatory agents from Sanwa Shoyaku

Jan. 7, 1997

Cephalon files first NDA submission

Jan. 3, 1997

Cambridge NeuroScience/Gladstone Institute AD collaboration

Jan. 3, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

Nippon Zoki claims aFGF fragments for CNS indications

Jan. 3, 1997

Debate centers on the safety of coated aspirin

Jan. 2, 1997

Antidementia agents reported by Eisai

Jan. 2, 1997

Novel anticonvulsant approved by FDA

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...